肥胖成因的解释——基于食物奖赏研究的视角

肥胖的形成和发展受生物、心理和社会因素的共同作用,其中食物奖赏对肥胖的产生有重要的作用。食物是一种自然奖赏,它指机体天生对食物的渴望和依赖。食物奖赏包括"wanting"、"liking"以及"learningreinforcement"三个成分,每个成分由相应的神经通路表征。食物奖赏调控机体的摄食行为并以此调控体重变化。目前,关于肥胖与食物奖赏关系的理论模型主要有刺激—敏感化理论、奖赏过度理论以及奖赏不足理论。采用横断面设计、前瞻研究设计和纵向被试内重复测量设计,使用食物图片线索和直接给予美味奶昔的技术方法,人类脑成像研究从不同侧面为以上三个理论模型提供了证据。除此之外,食物奖赏还受基因的调控。目前,研究者关注较多的是多巴胺D2受体基因Taq IA rs1800497的多态性和FTO基因rs9939609的多态性对食物奖赏及体重改变的调控。     

刺激前负波:奖赏期待的电生理指标

刺激前负波(Stimulus-Preceding Negativity,SPN)是从关联性负变化中分离出来的非运动性慢电位,其波幅随着反馈刺激的临近逐渐升高。先前研究侧重于将SPN视为一种认知性成分,而最近的研究支持了SPN是奖赏期待的可靠指标。本文从奖赏的基本属性、结果评价、神经发生源以及特殊人群等角度,对SPN反映奖赏期待这一假说进行了梳理,并提出了未来的研究方向,旨在为研究奖赏期待受损的神经精神类疾病提供可靠的生物学标记。     

奖赏性线索启动和调控视觉搜索额顶网络的神经机制

近期关于奖赏性信息与视觉搜索任务的交互作用研究体现在两个层面, 其一是施加外部奖赏能够影响被试的视觉搜索反应时和正确率, 其二是搜索目标本身具有奖赏特性也能够影响行为反应。但是, 奖赏性信息对负责视觉搜索的额顶注意网络的动态启动和调控作用仍不清楚。本研究结合Posner空间预提示范式和视觉搜索范式, 采用快速事件相关功能磁共振成像技术, 分别操纵线索提示阶段的线索奖赏属性(奖赏性vs.非奖赏性)和线索空间注意属性(有效提示目标位置vs.无效提示目标位置), 并操纵目标搜索阶段的目标属性(奖赏性vs.非奖赏性), 探讨以下两个核心问题：(1)在线索提示阶段, 奖赏性线索产生的自上而下注意准备信号的神经基础, 以及该神经基础与传统的空间注意准备信号的异同; (2)在目标搜索阶段, 奖赏性线索对负责视觉搜索的额顶注意网络产生的启动和调控作用, 重点考察对正确的奖赏性信息的定向过程和对错误的奖赏性信息的重新定向过程。     

睡眠质量对冒险行为影响的证据及解析

睡眠质量影响个体冒险行为已得到许多研究的验证和支持。睡眠缺失既影响大脑前额叶功能的完整性, 也影响杏仁核、纹状体等脑区的激活, 从而降低了个体对危险的知觉和对损失的敏感, 导致冒险意愿和冒险行为增加。已往相关研究多以成人群体为研究对象, 且忽略了个体特质与所处社会环境在睡眠质量与冒险行为关系中的交互影响。由于青少年期睡眠不足和高冒险行为普遍存在, 未来研究应对青少年睡眠质量与冒险行为的关系及其中的影响作用机制, 尤其是神经机制给予更多关注。     

赌博障碍的认知功能缺陷及神经基础

赌博障碍是指持续且反复的赌博行为,给个人、家庭和社会都带来了严重后果,近年来受到越来越多研究者的关注。本研究总结了赌博障碍的认知功能缺陷及其神经基础,主要集中在如下四个方面：①认知扭曲、②奖赏和惩罚敏感性、③注意偏向和④决策。未来研究应多从认知神经科学角度深入探究赌博障碍的发生机制和发展过程,关注大脑结构变化及功能网络改变,并将其整合到一个统一的神经生物机制框架中,找到更加有效的干预和治疗手段。     

Response rate correlates with indifference points in a delay‐discounting procedure

To study how effort affects reward value, we replicated Fortes, Vasconcelos and Machado's (2015) study using an adjusting‐delay task. Nine pigeons chose between a standard alternative that gave access to 4 s of food, after a 10 s delay, and an adjusting‐delay alternative that gave access to 12 s of food after a delay that changed dynamically with the pigeons' choices, decreasing when they preferred the standard alternative, and increasing when they preferred the adjusting alternative. The delay value at which preference stabilized defined the indifference point, a measure of reward value. To manipulate effort across phases, we varied the response rate required during the delay of the standard alternative. Results showed that a) the indifference point increased in the higher‐response‐rate phases, suggesting that reward value decreased with effort, and b) in the higher‐response‐rate phases, response rate in the standard alternative was linearly related to the indifference point. We advance several conceptions of how effort may change perceived delay or amount and thereby affect reward value.     

Age‐related differences in delay discounting: Immediate reward,reward magnitude,and social influence

Delay discounting refers to the tendency of individuals to subjectively devalue rewards that are to be received in the future, with high rates of delay discounting being associated with a variety of maladaptive life outcomes (e.g., unhealthy dietary and exercise behaviors). The current study explored the psychological and social processes involved in adult age‐related differences in delay discounting of monetary rewards. Younger adults exhibited higher levels of delay discounting than older adults. This increased level of patience in older adults was found whether smaller‐sooner rewards were to be received immediately or in the future. However, there was an interaction with reward magnitude, whereby younger adults exhibited higher levels of delay discounting for smaller reward magnitudes but not larger reward magnitudes. Social influence on delay discounting was investigated by having participants complete three phases of the delay‐discounting task: an individual precollaboration phase, a collaboration phase in age‐group‐matched dyads, and an individual postcollaboration phase. A convergence effect was observed in that dyad members' postcollaboration choices were significantly more similar compared to their baseline choices during the precollaboration phase. Moreover, levels of convergence were comparable between younger and older adults, suggesting age invariance in social influence on delay discounting. The current results demonstrate a degree of malleability in delay discounting that extends into older adulthood, making interventions targeting the construct a promising avenue for future research.     

Toward a Mechanistic Understanding of Human Decision Making: Contributions of Functional Neuroimaging

ABSTRACT— This article considers the contribution of functional neuroimaging toward understanding the computational underpinnings of human decision making. We outline the main processes likely underlying the capacity to make simple choices and describe their associated neural substrates. Relevant processes include the ability to encode a representation of the expected value or utility associated with each option in a decision problem, to learn such expectations through experience, and to modify action selection in order to choose those actions leading to the greatest reward. We provide several examples of how functional neuroimaging data have helped to shape and inform theories of decision making over and above results available from traditional behavioral measures.     

奖惩中枢与学习

奖惩现象及实验揭示了:兴奋了奖赏中枢的思想、行为(神经通路)能被奖赏中枢强烈易化,而兴奋了惩罚中枢的思想、行为能被惩罚中枢强烈抑制。在此基础上,通过讨论奖惩中枢在学习中的作用得出:思想、行为的动力由奖惩中枢影响产生;奖惩中枢在思想、行为(神经兴奋)习惯的选择、形成过程中起着主要作用。     

The biochemical bases of the placebo effect

A great variety of medical conditions are subject to the placebo effect. Although there is mounting evidence to suggest that the placebo effect is related to the expectation of clinical benefit, little is still known about the biochemical bases underlying placebo responses. Positron emission tomography studies have recently shown that the placebo effect in Parkinson’s disease, pain, and depression is related to the activation of the limbic circuitry. The observation that placebo administration induces the release of dopamine in the ventral striatum of patients with Parkinson’s disease suggests a link between the placebo effect and reward mechanisms. In addition to Parkinson’s disease, the placebo-reward model may also apply to other disorders. However, the relative contribution of the different neurotransmitters and neuropeptides that are known to be involved in modulating the activity of the limbic system may be disease-specific. Thus, while the placebo-induced clinical benefit observed in Parkinson’s disease would mostly reflect the release of dopamine in the dorsal striatum, the activation of opioid and serotonin pathways could be particularly implicated in mediating placebo responses encountered in pain and depression, respectively. An earlier version of this paper was presented at an international conference, “Placebo: Its Action and Place in Health Research Today,” held in Warsaw, Poland on 12–13 April, 2003.